Members of US Congress and State Officials call for action against the EU CSDDD and CSRD.
Michael R Pfeuffer | Morgan Lewis
The final part of our series considers ownership and use rights when leveraging GenAI.
The third part of our series considers where and how a company’s service provider is using GenAI and whether there is full disclosure of such use.
The second part of our series considers balancing the company’s need for enhanced quality checks with the desire (by the company and the outsourcing provider) to realize savings.
The opportunities offered by AI can be a test for constructing effective compliance and legal policies. We take a look at how to tackle the conundrum.